{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:18:43Z","timestamp":1788347923259,"version":"build-2803163510"},"reference-count":45,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202264023","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T12:25:34Z","timestamp":1647001534000},"source":"Crossref","is-referenced-by-count":16,"title":["Plasmodium falciparum merozoite surface protein 3 as a vaccine candidate: a brief review"],"prefix":"10.1590","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3705-4067","authenticated-orcid":false,"given":"K\u00e9ssia Caroline Souza","family":"Alves","sequence":"first","affiliation":[{"name":"Instituto Le\u00f4nidas e Maria Deane,  Brazil; Universidade Federal do Amazonas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jander Matos","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Amazonas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-5409","authenticated-orcid":false,"given":"Maria Edilene Martins de","family":"Almeida","sequence":"additional","affiliation":[{"name":"Instituto Oswaldo Cruz,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4210-6367","authenticated-orcid":false,"given":"Lu\u00eds Andr\u00e9 Morais","family":"Mari\u00faba","sequence":"additional","affiliation":[{"name":"Instituto Le\u00f4nidas e Maria Deane,  Brazil; Universidade Federal do Amazonas,  Brazil; Instituto Oswaldo Cruz,  Brazil; Universidade Federal do Amazonas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2022]]},"reference":[{"key":"ref1","series-title":"World malaria report 2019"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.01636-09","article-title":"Increased tolerance to artemisinin in plasmodium falciparum is mediated by a quiescence mechanism","volume":"54","author":"Witkowski B","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/ciw388","article-title":"Declining efficacy of artemisinin combination therapy against P. Falciparum malaria on the Thai-Myanmar Border (2003-2013): the role of parasite genetic factors","volume":"63","author":"Phyo AP","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin\u2013piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm RW","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.immuni.2010.10.005","article-title":"Malaria vaccine design: immunological considerations","volume":"33","author":"Good MF","year":"2010","journal-title":"Immunity"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-3024.2006.00775.x","article-title":"Regulating immunity to malaria","volume":"28","author":"Riley EM","year":"2006","journal-title":"Parasite Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4161\/hv.6.9.12468","article-title":"Malaria vaccine development based on merozoite surface proteins of Plasmodium falciparum","volume":"6","author":"Chauahan VS","year":"2010","journal-title":"Hum Vaccin"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.vaccine.2005.01.046","article-title":"Malaria vaccines: using models of immunity and functional genomics tools to accelerate the development of vaccines against Plasmodium falciparum","volume":"23","author":"Duffy PE","year":"2005","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/expr.1998.4257","article-title":"Plasmodium falciparum: thrombospondin mediates parasitized erythrocyte band 3-related adhesin binding","volume":"89","author":"Lucas JZ","year":"1998","journal-title":"Exp Parasitol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3389\/fimmu.2019.01995","article-title":"Parasite-produced MIF cytokine: role in immune evasion, invasion, and pathogenesis","volume":"10","author":"Ghosh S","year":"2019","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature24994","article-title":"Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors","volume":"552","author":"Saito F","year":"2017","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41541-017-0015-7","article-title":"A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection","volume":"2","author":"Srinivasan P","year":"2017","journal-title":"NPJ Vaccines"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pt.2015.02.001","article-title":"PfRH5 as a candidate vaccine for Plasmodium falciparum malaria","volume":"31","author":"Drew DR","year":"2015","journal-title":"Trends Parasitol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.vaccine.2006.09.074","article-title":"A review of human vaccine research and development: malaria","volume":"25","author":"Girard MP","year":"2007","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025786","article-title":"Circumsporozoite-specific T cell responses in children vaccinated with RTS,S\/AS01E and protection against P falciparum clinical malaria","volume":"6","author":"Olotu A","year":"2011","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061395","article-title":"The relationship between RTS,S vaccine-induced antibodies, CD4+ T cell responses and protection against Plasmodium falciparum infection","volume":"8","author":"White MT","year":"2013","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0166-6851(97)00130-8","article-title":"Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3)","volume":"90","author":"McColl DJ","year":"1997","journal-title":"Mol Biochem Parasitol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S0074-02761994000600018","article-title":"A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies","volume":"89","author":"Oeuvray C","year":"1994","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1074\/jbc.M113.520239","article-title":"Plasmodium falciparum merozoite surface protein 3: oligomerization, self-assembly, and heme complex formation","volume":"289","author":"Imam M","year":"2014","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e00067-18","DOI":"10.1128\/IAI.00067-18","article-title":"Plasmodium falciparum MSP3 exists in a complex on the merozoite surface and generates antibody response during natural Infection","volume":"86","author":"Deshmukh A","year":"2018","journal-title":"Infect Immun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molbiopara.2004.09.012","article-title":"Characterisation of two novel proteins from the asexual stage of Plasmodium falciparum, H101 and H103","volume":"139","author":"Pearce JA","year":"2005","journal-title":"Mol Biochem Parasitol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/423208","article-title":"Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design","volume":"190","author":"Singh S","year":"2004","journal-title":"J Infect Dis"},{"key":"ref23","first-page":"231","article-title":"Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3","volume":"87","author":"Huber W","year":"1997","journal-title":"Mol Biochem Parasitol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/iai.60.4.1473-1481.1992","article-title":"Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity","volume":"60","author":"Bouharoun-Tayoun H","year":"1992","journal-title":"Infect Immun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s12936-016-1566-1","article-title":"Genetic diversity of the merozoite surface protein-3 gene in Plasmodium falciparum populations in Thailand","volume":"15","author":"Pattaradilokrat S","year":"2016","journal-title":"Malar J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-3024.2009.01130.x","article-title":"Humoral and cell-mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso","volume":"31","author":"Nebie I","year":"2009","journal-title":"Parasite Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.vaccine.2003.09.017","article-title":"A Plasmodium falciparum GLURP\u2013MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies","volume":"22","author":"Theisen M","year":"2004","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/IAI.00941-08","article-title":"Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of immunogenicity studies in models","volume":"78","author":"Daher LJ","year":"2010","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1074\/jbc.M115.698282","article-title":"Multiple Plasmodium falciparum merozoite surface protein 1 complexes mediate merozoite binding to human erythrocytes","volume":"291","author":"Lin CS","year":"2016","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/339187","article-title":"Merozoite surface protein 3 and protection against malaria in Aotus monkeys","volume":"185","author":"Hisaeda H","year":"2002","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.0300-9475.2004.01409.x","article-title":"Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels","volume":"59","author":"Carvalho LJ","year":"2004","journal-title":"Scand J Immunol"},{"key":"ref32","first-page":"242","article-title":"Immunization of Saimiri sciureus monkeys with a recombinant hybrid protein derived from the Plasmodium falciparum antigen glutamate-rich protein and merozoite surface protein 3 can induce partial protection with Freund and Montanide ISA720 adjuvants","volume":"12","author":"Carvalho LJ","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/423208","article-title":"Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design","volume":"190","author":"Singh S","year":"2004","journal-title":"J Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020344","article-title":"A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum","volume":"2","author":"Druilhe P","year":"2005","journal-title":"PLoS Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.vaccine.2006.05.090","article-title":"Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa","volume":"25","author":"Sirima SB","year":"2007","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1475-2875-8-163","article-title":"Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12\u201324 months","volume":"8","author":"Lusingu JP","year":"2009","journal-title":"Malar J"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007549","article-title":"Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children","volume":"4","author":"Sirima SB","year":"2009","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1016\/j.vaccine.2009.09.011","article-title":"Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate","volume":"27","author":"Esen M","year":"2009","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1016\/j.vaccine.2010.07.085","article-title":"Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambar\u00e9n\u00e9, Gabon","volume":"28","author":"Mordm\u00fcller B","year":"2010","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022525","article-title":"A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children","volume":"6","author":"B\u00e9lard S","year":"2011","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1016\/j.vaccine.2016.07.041","article-title":"A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children","volume":"34","author":"Sirima SB","year":"2016","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1016\/j.vaccine.2021.06.024","article-title":"Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine","volume":"39","author":"Dassah S","year":"2021","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciy1087","article-title":"Controlled human malaria infection of healthy adults with lifelong malaria exposure to assess safety, immunogenicity, and efficacy of the asexual blood stage malaria vaccine candidate GMZ2","volume":"69","author":"Dejon-Agobe JC","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"332","key":"ref44","article-title":"Effect of hookworm infection and anthelmintic treatment on naturally acquired antibody responses against the GMZ2 malaria vaccine candidate and constituent antigens","volume":"21","author":"Amoani B","year":"2021","journal-title":"BMC Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009361","article-title":"Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2","volume":"15","author":"Nouatin O","year":"2021","journal-title":"PLOS Negl Trop Dis"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v64\/1678-9946-rimtsp-64-S1678-9946202264023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T12:26:15Z","timestamp":1647001575000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652022000100401&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":45,"alternative-id":["S0036-46652022000100401"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202264023","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"e23"}}